Download Your Complimentary Copy of the Agenda

The 3rd TRP Target Selection & Drug Design Summit is your exclusive forum to learn, network and partner with the brightest minds revolutionising the TRP industry.

100+ RLT Experts Under One Roof

Connect with scientific and strategic leaders from AstraZeneca, Bayer, Pfizer, Molecular Partners, Mariana Oncology, ex-FDA, and beyond.
Identify the Next High-Potential RLT Target
Explore novel biology and mine clinically validated targets from ADCs, T-cell engagers, bispecifics, RDCs, and other targeted modalities.

Design More Differentiated Radio-Therapeutics

Optimize targeting moieties, binders, radionuclides, linkers, and chelators to improve biodistribution, tumor retention, and therapeutic potential.

Strengthen Preclinical Confidence

Benchmark translational models, dosimetry, radiobiology, and safety strategies to build stronger evidence and progress candidates toward the clinic.

Build Partnerships Across the RLT Ecosystem

Connect through speed networking, interactive workshops, roundtables, poster sessions, and dedicated discussions with the discovery and preclinical community

3rd TRP Target Selection & Drug Design Summit Brochure Photo

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Attending Companies Include

AstraZeneca
Bayer
Ex-FDA at 3rd TRP Target Selection & Drug Design Summit
Harvard Medical School at 3rd TRP Target Selection & Drug Design Summit
Matrisome Bio at 3rd TRP Target Selection & Drug Design Summit
Molecular Partners at 3rd TRP Target Selection & Drug Design Summit
Ratio Therapeutics at 3rd TRP Target Selection & Drug Design Summit
United Theranostics at 3rd TRP Target Selection & Drug Design Summit
University of Osaka at 3rd TRP Target Selection & Drug Design Summit